Grant - Valneva
Investment Firm
Overview
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Announced Date
Feb 21, 2022
Funding Type
Grant
Highlights
Location
Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Valneva raised $27190390 on 2022-02-21 in Grant
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Company Funding History
15
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 09, 2021 |  Post-IPO Equity - Valneva | - | 17.0M | |
| Jul 22, 2024 | Grant - Valneva | 2 | - | 41.3M |
| Jul 12, 2016 | Post-IPO Debt - Valneva | - | 27.7M | |
| Jun 13, 2013 | Post-IPO Equity - Valneva | - | 53.7M |
Recent Activity
There is no recent news or activity for this profile.